✅ Model Answer:
• Dilated posterior urethra – "spinning top" or "wind sock" appearance.
• Bladder trabeculation – irregular bladder wall from chronic obstruction.
• Vesicoureteral reflux – contrast reflux into ureters (bilateral or unilateral).
• Narrowed membranous urethra – valve leaflets at the level of the verumontanum.
• Thickened bladder wall – with diverticula or cellules.
• Diagnosis: Posterior urethral valves (PUV).

✅ Model Answer:
• PUV are congenital mucosal folds in the posterior urethra, located at the level of the verumontanum (proximal to the membranous urethra).
• They cause bladder outlet obstruction → increased bladder pressure → bladder wall hypertrophy and trabeculation.
• The obstruction leads to vesicoureteral reflux (VUR) in 50-70% of cases, causing hydronephrosis and renal parenchymal damage.
• It also causes renal dysplasia (abnormal renal development) – a major cause of chronic kidney disease (CKD).
• Prenatally, PUV can cause oligohydramnios (due to reduced urine output) → Potter sequence (pulmonary hypoplasia, limb deformities).
• The severity of renal damage depends on the degree and duration of obstruction.

✅ Model Answer:
• Prenatal: Bilateral hydronephrosis, dilated bladder, oligohydramnios (seen on antenatal ultrasound).
• Newborn:
- Poor urinary stream – weak or dribbling stream.
- Palpable bladder – distended bladder on examination.
- Distended abdomen – due to megacystis or hydronephrosis.
- Failure to thrive, poor feeding, vomiting.
- Urinary ascites – if bladder rupture occurs.
- Respiratory distress – due to pulmonary hypoplasia from oligohydramnios.
- Key sign: Palpable bladder in a male neonate with weak stream is highly suggestive of PUV.
- Urine output: May appear normal initially (due to polyuria from renal concentrating defect).

✅ Model Answer:
• This is a urological emergency – requires immediate decompression.
• Immediate management:
1. Urinary catheterization: Insert a size 8 Fr feeding tube (or 5 Fr if smaller) to drain the bladder. This relieves the obstruction and prevents further renal damage.
2. Check post-void residual: To confirm adequate drainage.
3. Monitor urine output: Measure hourly.
4. Start IV fluids: To maintain hydration and correct electrolyte imbalances (if present).
5. Blood tests: Renal function (creatinine, BUN), electrolytes, and blood gas (to assess acidosis).
6. Antibiotics: If UTI is suspected.
7. Ultrasound: To assess hydronephrosis and bladder distention.
8. Definitive management: Endoscopic valve ablation (after stabilization).

✅ Model Answer:
• MCUG is the gold standard for diagnosing PUV.
• Classic findings:
1. Dilated posterior urethra: The posterior urethra appears widened, giving a "spinning top" or "wind sock" appearance.
2. Bladder trabeculation: Irregular bladder wall contour (due to chronic high pressure).
3. Vesicoureteral reflux (VUR): Contrast reflux into the ureters (unilateral or bilateral).
4. Narrowed membranous urethra: A thin line of contrast at the level of the valve leaflets.
5. Thickened bladder wall: With possible diverticula or cellules.
6. Post-void residual: Incomplete bladder emptying.
• MCUG should be performed in all male neonates with suspected PUV.

✅ Model Answer:
• The definitive treatment is endoscopic valve ablation (transurethral resection or incision of the valves).
• Procedure: A cystoscope is inserted into the urethra, and the valve leaflets are cut or fulgurated.
• Timing: Usually performed after stabilization (within the first few weeks of life).
• Success rate: Good, but some patients may require repeat ablation.
• Alternative (rare): Urinary diversion (vesicostomy or ureterostomy) if the infant is too small for endoscopic ablation.
• Post-ablation: Monitor for improvement in hydronephrosis, renal function, and bladder function.
• Long-term: Many patients have residual bladder dysfunction (voiding dysfunction) requiring bladder training, anticholinergics, and clean intermittent catheterization (CIC).

✅ Model Answer:
• This is recurrent pyelonephritis – likely due to VUR and bladder dysfunction.
• Management:
1. Antibiotics: Treat acute UTI with IV antibiotics (e.g., ampicillin + gentamicin, or ceftriaxone).
2. Renal ultrasound: Assess for hydronephrosis and renal size.
3. VCUG: To assess for persistent VUR and bladder emptying.
4. DMSA scan: To evaluate renal scarring and differential function.
5. Urodynamics: To assess bladder pressure and compliance.
6. Antibiotic prophylaxis: May be started if VUR is high-grade.
7. Clean intermittent catheterization (CIC): If there is significant bladder dysfunction.
8. Long-term: Monitor renal function and blood pressure.

✅ Model Answer:
• Renal:
- Chronic kidney disease (CKD) – up to 30-40% of patients develop end-stage renal disease (ESRD) by adolescence.
- Renal dysplasia (congenital renal damage).
- Proteinuria (a marker of progressive renal damage).
- Hypertension (due to renal damage).
• Bladder:
- Bladder dysfunction (detrusor instability, poor compliance).
- Incontinence (day and night) – due to bladder overactivity or poor compliance.
- Recurrent UTIs (due to VUR and stasis).
- Vesicoureteral reflux (persistent or recurrent).
• Other:
- Growth failure (from CKD and poor nutrition).
- Electrolyte imbalances (salt-wasting, acidosis).
- Anemia (renal failure).
- Need for renal transplantation (if ESRD develops).

✅ Model Answer:
• Urodynamics (cystometrogram) evaluates bladder pressure, capacity, and compliance.
• In PUV patients, common findings:
- Detrusor overactivity: Involuntary bladder contractions.
- Poor compliance: High pressure with small bladder volume (risk of upper tract damage).
- High voiding pressure: Incomplete bladder emptying.
• Role:
1. Helps guide management (anticholinergics, CIC, botulinum toxin).
2. Identifies patients at risk of upper tract damage.
3. Monitors response to treatment.
• Management of poor compliance:
- Anticholinergics (oxybutynin) to relax the bladder.
- Clean intermittent catheterization (CIC) to ensure complete emptying.
- Botulinum toxin injections (for refractory overactivity).
- Augmentation cystoplasty (surgical enlargement of the bladder) for severe cases.

✅ Model Answer:
• A creatinine of 1.5 mg/dL in a neonate indicates significant renal impairment (normal newborn creatinine is 0.3-0.7 mg/dL).
• This reflects renal dysplasia or obstructive nephropathy.
• Management:
1. Urgent relief of obstruction: Catheterization and valve ablation.
2. Monitor renal function: Serial creatinine measurements (may improve after obstruction relief).
3. Assess for electrolyte imbalances: Hyperkalemia, acidosis, hyponatremia (salt-wasting).
4. Fluid and electrolyte management: IV fluids, sodium bicarbonate if acidotic.
5. Nutritional support: To support growth.
6. Long-term: Nephrology referral for CKD management (dietary modifications, blood pressure control, anemia management).
7. Prognosis: Elevated neonatal creatinine is a poor prognostic indicator for long-term renal function.

✅ Model Answer:
• PUV can be diagnosed prenatally on routine obstetric ultrasound.
• Findings:
- Bilateral hydronephrosis.
- Dilated bladder (megacystis) with a thick wall (keyhole sign – dilated posterior urethra and bladder).
- Oligohydramnios (reduced amniotic fluid) – severe cases.
- Renal cortical thinning (dysplastic kidneys).
• Importance of prenatal diagnosis:
1. Allows for antenatal counseling (discuss prognosis and management).
2. Postnatal management planning: Delivery at a tertiary center with neonatology and pediatric urology.
3. Potential for fetal intervention: Vesicoamniotic shunting (in selected cases) to reduce renal damage.
4. Early neonatal management: Catheterization and valve ablation can be performed soon after birth to preserve renal function.